Xlife Sciences: David Deck, Founder and Head Senior Advisor; Oliver R. Baumann, CEO (from left to right)

Xlife Sciences: David Deck, Founder and Head Senior Advisor; Oliver R. Baumann, CEO (from left to right)

The shares of Xlife Sciences were listed with a reference price of CHF 44.71 per share on the new Sparks segment of SIX Swiss Exchange. At an opening price of CHF 48.79 per share, the company achieved a market capitalization of around CHF 254 million. Previously, the shares of Xlife Sciences were admitted to trading on an unregulated market (“Freiverkehr”) of a German stock exchange operator. Concurrently with the listing on SIX Swiss Exchange, the trading of the shares on such unregulated German market shall be ceased.

Trading of the shares of Xlife Sciences started today and will be daily and continuous from 3 p.m. until 5.20 p.m. – including closing auction and “Trading at Last (TAL)” until 5.40 p.m. in order to improve trading liquidity. All SMEs listed and traded on Sparks are subject to the same supervision and provisions as companies listed on the main market of SIX Swiss Exchange, which means that investors benefit from the same level of transparency and regulatory oversight.

Oliver R. Baumann, CEO of Xlife Sciences, says: “We look forward to tackling the next development steps as a Swiss-listed company. We are convinced that we are in the best of hands in the Sparks segment of SIX Swiss Exchange. By switching to this regulated stock exchange, we do not only increase transparency and liquidity, but also make Xlife Sciences more accessible, especially to long-term oriented institutional investors from Switzerland.”

Jos Dijsselhof, CEO SIX, emphasizes: “We are proud to see the first Sparks listing only 4 months after the launch of our new SME segment, which proves its attractiveness. A warm welcome to Xlife Sciences and great to see a Swiss company from the life sciences sector coming “back home” to Switzerland. Being first always takes an extra effort and courage. I thank Xlife Sciences for being the first mover and I wish them every success on their way forward as a SIX-listed public company.”

More information about Xlife Sciences: www.xlifesciences.ch

More information about Sparks: www.six-group.com/sparks

 
About SIX
SIX operates and develops infrastructure services for the Swiss and Spanish Stock Exchanges, for Post-Trade Services, Banking Services and Financial Information with the aim of raising efficiency, quality and innovative capacity across the entire value chain of the Swiss and Spanish financial centers. The company is owned by its users (120 banks). With a workforce of 3,685 employees and a presence in 20 countries, it generated operating income of CHF 1.5 billion and Group net profit of CHF 73.5 million in 2021.
www.six-group.com